Safety and immune response to a challenge dose of hepatitis B vaccine in healthy children primed 10 years earlier with hexavalent vaccines in a 3, 5, 11-month schedule: An open-label, controlled, multicentre trial in Italy

Vaccine ◽  
2017 ◽  
Vol 35 (32) ◽  
pp. 4034-4040 ◽  
Author(s):  
Alessandro Zanetti ◽  
Maria Giuseppina Desole ◽  
Luisa Romanò ◽  
Antonio d'Alessandro ◽  
Michele Conversano ◽  
...  
Vaccine ◽  
2021 ◽  
Vol 39 (8) ◽  
pp. 1265-1271
Author(s):  
E. Seremba ◽  
P. Ocama ◽  
R. Ssekitoleko ◽  
H. Mayanja-Kizza ◽  
S.V. Adams ◽  
...  

Vaccine ◽  
2021 ◽  
Author(s):  
Ahmed M. Awad ◽  
Adu Ntoso ◽  
Jeffrey J. Connaire ◽  
German T. Hernandez ◽  
Kiranjit Dhillon ◽  
...  

Vaccine ◽  
1991 ◽  
Vol 9 (10) ◽  
pp. 747-750 ◽  
Author(s):  
Giuseppe Giammanco ◽  
Salvatore Li Volti ◽  
Luisa Mauro ◽  
Giuseppe Giammanco Bilancia ◽  
Isabella Salemi ◽  
...  

1997 ◽  
Vol 41 (5) ◽  
pp. 771-771
Author(s):  
J P Panagiotou ◽  
S Polychronopoulou ◽  
S Kostaridou ◽  
K Spanou ◽  
O Moraloglou ◽  
...  

Vaccine ◽  
1992 ◽  
Vol 10 (11) ◽  
pp. 798-801 ◽  
Author(s):  
J.M. Rodrigo ◽  
M.A. Serra ◽  
L. Aparisi ◽  
A. Escudero ◽  
M.S. Gilabert ◽  
...  

Author(s):  
C. F. T. Yoshida ◽  
C. Takahashi ◽  
L. A. C. Mercadante ◽  
I. F. Camargo ◽  
H. G. Schatzmayr

Immune response against hepatitis B vaccine (CLB 3mg) was evaluated in 59 hemodialysis patients and 20 occupational risk personnel. Seroconversion was induced in 52.5% and 70.0% respectively. Twelve months after the first dose, 37.5% of patients and 60.0% of occupational risk personnel had detectable anti-HBs level. Antibody level was expressed in sample ratio units (SRU). Considering only the responders, in the patients group 38.7% had a low anti-HBs response (2.1-9.9 SRU) 32.3% a medium response (10-99.9 SRU) and 29.0% a high response (>100 SRU) while in occupational risk personnel these values were 14.3%, 64.3% and 21.4% respectively. The authors suggest the use of HBV vaccines with more elevated HBsAg concentration or a reinforced immunization schedule to improve the anti-HBs response not only for patients but also for healthy persons.


2020 ◽  
Vol 39 (9) ◽  
pp. 2751-2756 ◽  
Author(s):  
Patricia Richi ◽  
Oriol Alonso ◽  
María Dolores Martín ◽  
Laura González-Hombrado ◽  
Teresa Navío ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document